Allium cepa/Tendo comp. Injektionslösung (s.c.)

Country: Շվեյցարիա

language: գերմաներեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

buyitnow

active_ingredient:

allium cepa ferm 34a (HAB) D7, arnica montana e planta tota rec. ferm 33c D5 (HAB 33c), periosteum bovis Gl D16 (HAB 41b), stannum metallicum (HAB) D14, symphytum officinale e radice rec. ferm 34c D5 (HAB 34c), tendo bovis Gl D16 (HAB 41b), vaginae synoviales tendinum bovis Gl D16 (HAB 41c)

MAH:

WALA Schweiz AG

INN:

allium cepa ferm 34a (HAB) D7, arnica montana e planta tota rec. ferm 33c D5 (HAB 33c), periosteum bovis Gl D16 (HAB 41b), stannum metallicum (HAB) D14, symphytum officinale e radice rec. ferm 34c D5 (HAB 34c), tendo bovis Gl D16 (HAB 41b), vaginae synoviales tendinum bovis Gl D16 (HAB 41c)

pharmaceutical_form:

Injektionslösung (s.c.)

composition:

allium cepa ferm 34a (HAB) D7 100 mg, arnica montana e planta tota rec. ferm 33c D5 (HAB 33c) 100 mg, periosteum bovis Gl D16 (HAB 41b) 100 mg, stannum metallicum (HAB) D14 100 mg, symphytum officinale e radice rec. ferm 34c D5 (HAB 34c) 100 mg, tendo bovis Gl D16 (HAB 41b) 100 mg, vaginae synoviales tendinum bovis Gl D16 (HAB 41c) 100 mg, natrii chloridum, natrii hydrogenocarbonas, aqua ad iniectabile, pro vitro 1 ml corresp. natrium 3.51 mg.

class:

B

therapeutic_group:

Anthroposophische Arzneimittel

therapeutic_area:

Zulassung mit reduziertem Dossier ohne Indikation nach Art. 25 Abs. 1 KPAV (SR 812.212.24)

authorization_status:

zugelassen

authorization_date:

2011-05-31

documents_in_other_languages

PIL PIL ֆրանսերեն 29-05-2024
SPC SPC ֆրանսերեն 29-05-2024
PIL PIL իտալերեն 29-05-2024
SPC SPC իտալերեն 29-05-2024